| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.50B | -16.7% |
| Cost of Revenue | $824.6M | -22.0% |
| R&D Expense | $43.1M | -12.4% |
| SG&A Expense | $381.5M | -9.7% |
| Operating Income | $1.41B | +40.6% |
| Interest Expense | $138.8M | +9.3% |
| Pre-tax Income | $1.26B | +44.2% |
| Income Tax | $220.3M | +5.4% |
| Net Income | $953.9M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $112.5M | -59.9% |
| Accounts Receivable | $290.1M | -35.0% |
| Current Assets | $925.1M | +2.5% |
| Total Assets | $6.96B | -10.8% |
| Current Liabilities | $2.32B | +25.8% |
| Long-term Debt | $3.74B | +12.7% |
| Total Liabilities | $5.19B | +4.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.06B | -8.4% |
| Capital Expenditures | $274.7M | +2.3% |
| Investing Cash Flow | $301.4M | +150.9% |
| Financing Cash Flow | -$1.33B | -166.6% |
| Free Cash Flow | $784.3M | -11.6% |
| +43.2% |
| EPS (Basic) | $6.04 | +46.6% |
| EPS (Diluted) | $6.00 | +47.1% |
| Stockholders' Equity |
| $1.75B |
| -37.9% |